BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shun CT, Lin JT, Huang SP, Lin MT, Wu MS. Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol 2005; 11(24): 3767-3771 [PMID: 15968736 DOI: 10.3748/wjg.v11.i24.3767]
URL: https://www.wjgnet.com/1007-9327/full/v11/i24/3767.htm
Number Citing Articles
1
Nasser H. Goradel, Nejad Mohammadi, Hamed Haghi‐Aminjan, Bagher Farhood, Babak Negahdari, Amirhossein Sahebkar. Regulation of tumor angiogenesis by microRNAs: State of the artJournal of Cellular Physiology 2019; 234(2): 1099 doi: 10.1002/jcp.27051
2
Guo-Qing Li, Juan Xie, Xiao-Yong Lei, Li Zhang. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells <italic>via</italic> the PI3K/Akt pathwayWorld Journal of Gastroenterology 2009; 15(44): 5541-5548 doi: 10.3748/wjg.15.5541
3
Majid Nabizadeh Marvast, Hamid Reza Sima, Kamran Ghaffarzadehgan, Ali Taghizadeh Kermani, Nona Norouzi. Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric CancerJournal of Gastrointestinal Cancer 2011; 42(1): 5 doi: 10.1007/s12029-010-9215-3
4
Afraa Mamoori, Vinod Gopalan, Cu-Tai Lu, Terence C Chua, David L Morris, Robert Anthony Smith, Alfred K-Y Lam. Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancerJournal of Clinical Pathology 2017; 70(4): 308 doi: 10.1136/jclinpath-2016-203972
5
Litao Jia, Jiamin Chen, Chuangao Xie, Liming Shao, Zhipeng Xu, Lu Zhang. microRNA-1228⁎ impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factorLife Sciences 2017; 180: 9 doi: 10.1016/j.lfs.2017.04.023
6
Xing-Xiang He, Ken Chen, Jun Yang, Xiao-Yu Li, Huo-Ye Gan, Cheng-Yong Liu, Thomas R. Coleman, Yousef Al-Abed. Macrophage Migration Inhibitory Factor Promotes Colorectal CancerMolecular Medicine 2009; 15(1-2): 1 doi: 10.2119/molmed.2008.00107
7
Marc McClelland, Liujian Zhao, Shannon Carskadon, Douglas Arenberg. Expression of CD74, the Receptor for Macrophage Migration Inhibitory Factor, in Non-Small Cell Lung CancerThe American Journal of Pathology 2009; 174(2): 638 doi: 10.2353/ajpath.2009.080463
8
Fanyang Kong, Xuan Deng, Xiangyu Kong, Yiqi Du, Lei Li, Huiyun Zhu, Yuxin Wang, Dacheng Xie, Shivani Guha, Zhaoshen Li, Ming Guan, Keping Xie. ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIFOncogene 2018; 37(45): 5982 doi: 10.1038/s41388-018-0387-9
9
Chengjie Xiong, Bo Huang, Yanping Cun, Bayan G. Aghdasi, Yue Zhou. Migration Inhibitory Factor Enhances Inflammation via CD74 in Cartilage End Plates with Modic Type 1 Changes on MRIClinical Orthopaedics & Related Research 2014; 472(6): 1943 doi: 10.1007/s11999-014-3508-y
10
Ahmed M. Abu El-Asrar, Ajmal Ahmad, Mohammad Mairaj Siddiquei, Alexandra De Zutter, Eef Allegaert, Priscilla W. Gikandi, Gert De Hertogh, Jo Van Damme, Ghislain Opdenakker, Sofie Struyf. The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic RetinopathyFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02752
11
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cellsGastric Cancer 2023; 26(1): 55 doi: 10.1007/s10120-022-01338-1
12
Jennifer M. Noto, Kristie L. Rose, Amanda J. Hachey, Alberto G. Delgado, Judith Romero-Gallo, Lydia E. Wroblewski, Barbara G. Schneider, Shailja C. Shah, Timothy L. Cover, Keith T. Wilson, Dawn A. Israel, Juan Carlos Roa, Kevin L. Schey, Yana Zavros, M. Blanca Piazuelo, Richard M. Peek. Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression*Molecular & Cellular Proteomics 2019; 18(2): 352 doi: 10.1074/mcp.RA118.001181
13
Byeong Bae Park, Jin sun Yoon, Eun shil Kim, Jiyoung Choi, Young woong Won, Jung hye Choi, Young Yiul Lee. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cellsTumor Biology 2013; 34(2): 875 doi: 10.1007/s13277-012-0621-y
14
Yejin Zhang, Lin Zheng, Jiawei Fang, Kainan Ni, Xingyu Hu, Lin Ye, Hehuan Lai, Tao Yang, Zhenzhong Chen, Dengwei He. Macrophage migration inhibitory factor (MIF) promotes intervertebral disc degeneration through the NF‐κB pathway, and the MIF inhibitor CPSI‐1306 alleviates intervertebral disc degeneration in a mouse modelThe FASEB Journal 2023; 37(12) doi: 10.1096/fj.202301441R
15
Millicent Winner, Albert C. Koong, Beatriz E. Rendon, Wayne Zundel, Robert A. Mitchell. Amplification of Tumor Hypoxic Responses by Macrophage Migration Inhibitory Factor–Dependent Hypoxia-Inducible Factor StabilizationCancer Research 2007; 67(1): 186 doi: 10.1158/0008-5472.CAN-06-3292
16
Paola Viganò, Marcella Cintorino, Frederick Schatz, Charles J. Lockwood, Felice Arcuri. The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal–maternal interfaceSeminars in Immunopathology 2007; 29(2) doi: 10.1007/s00281-007-0074-3
17
Jason A. Chesney, Robert A. Mitchell. 25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor AngiogenesisMolecular Medicine 2015; 21(S1): S19 doi: 10.2119/molmed.2015.00055
18
Harry Hua‐Xiang Xia, Yi Yang, Kent‐Man Chu, Qing Gu, Yuan‐Yuan Zhang, Hua He, Wai Man Wong, Suet‐Yi Leung, Siu‐Tsan Yuen, Man‐Fung Yuen, Annie O.O. Chan, Benjamin C.Y. Wong. Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancerCancer 2009; 115(23): 5441 doi: 10.1002/cncr.24609
19
Millicent Winner, Lin Leng, Wayne Zundel, Robert A. Mitchell. Oxygen Biology and HypoxiaMethods in Enzymology 2007; 435: 355 doi: 10.1016/S0076-6879(07)35018-0
20
Gregor Reid. Genomic Instability and Cancer MetastasisCancer Metastasis - Biology and Treatment 2015; 20: 159 doi: 10.1007/978-3-319-12136-9_8
21
Beatriz E. Rendon, Sharon S. Willer, Wayne Zundel, Robert A. Mitchell. Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptationExperimental and Molecular Pathology 2009; 86(3): 180 doi: 10.1016/j.yexmp.2009.01.001
22
Dong-Sic Choi, Jae-Min Lee, Gun Wook Park, Hyeon-Woo Lim, Joo Young Bang, Yoon-Keun Kim, Kyung-Hoon Kwon, Ho Jeong Kwon, Kwang Pyo Kim, Yong Song Gho. Proteomic Analysis of Microvesicles Derived from Human Colorectal Cancer CellsJournal of Proteome Research 2007; 6(12): 4646 doi: 10.1021/pr070192y
23
Jérôme Lugrin, Xavier C. Ding, Didier Le Roy, Anne-Laure Chanson, Fred C.G.J. Sweep, Thierry Calandra, Thierry Roger. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2009; 1793(11): 1749 doi: 10.1016/j.bbamcr.2009.09.007
24
Rasoul Estakhri, Kourosh Masnadi Shirazi, Morteza Ghojazadeh, Gilda Ghazisoltani, Mahzad Azimpouran, Sepideh Fattahi, Jalal Farshbafi Nezhad Zoghi, Farid Karkon Shayan, Behnaz Ghamari. The diagnostic value of macrophage migration inhibitory factor, carcinoembryonic antigen, and carbohydrate antigen 19-9 in gastric cancerJournal of Analytical Research in Clinical Medicine 2018; 6(4): 179 doi: 10.15171/jarcm.2018.029
25
Oriana E. Hawkins, Rodney S. VanGundy, Annette M. Eckerd, Wilfried Bardet, Rico Buchli, Jon A. Weidanz, William H. Hildebrand. Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201Journal of Proteome Research 2008; 7(4): 1445 doi: 10.1021/pr700761w
26
N J Shimwell, D G Ward, Y Mohri, T Mohri, L Pallan, M Teng, Y C Miki, M Kusunoki, O Tucker, W Wei, J Morse, P J Johnson. Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areasBritish Journal of Cancer 2012; 107(9): 1595 doi: 10.1038/bjc.2012.405